Aroa Biosurgery Limited (ASX:ARX)


right-arrow Created with Sketch. -0.015 (-1.54%)
MCAP $333.7M
Last trade 11.15am 19/01/2022 20mins delayed

Latest Announcements

13/01/2022ARXAroa Biosurgery Limited
07/12/2021ARXAroa Biosurgery Limited
07/12/2021ARXAroa Biosurgery Limited
25/11/2021ARXAroa Biosurgery Limited
25/11/2021 Price SensitivePSARXAroa Biosurgery Limited
25/11/2021 Price SensitivePSARXAroa Biosurgery Limited
11/11/2021ARXAroa Biosurgery Limited
09/11/2021ARXAroa Biosurgery Limited

Company Overview

Aroa Biosurgery Limited is a New Zealand-based soft tissue repair company. The Company is engaged in commercializing regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. It designs and manufactures medical products which enable surgeons and clinicians to repair serious tissue injuries. The Company’s solutions include Endoform platform, Wound Care Portfolio and Reinforced Bioscaffolds. The Endoform platform is a building block for developing a range of regenerative tissue substitutes to assist with tissue repair and healing. Its wound care products comprise extracellular matrix to manage acute and chronic wounds. The Reinforced Bioscaffolds combine the biologics and synthetics to address the surgical ventral hernia repair solutions.

ARX in the news

Aroa Biosurgery (ARX) posts healthy gains on the ASX today after releasing…
Aroa Biosurgery (ARX) has received U.S. Food and Drug Administration (FDA) 510(k)…
Aroa Biosurgery (ARX) officially joined the ASX today after a $45 million…

Search Previous Announcements